Krilogy Financial LLC Takes $867,000 Position in Teleflex Incorporated $TFX

Krilogy Financial LLC bought a new position in shares of Teleflex Incorporated (NYSE:TFX) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 6,947 shares of the medical technology company’s stock, valued at approximately $867,000.

Several other institutional investors have also added to or reduced their stakes in TFX. MassMutual Private Wealth & Trust FSB grew its holdings in Teleflex by 57.9% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after buying an additional 77 shares in the last quarter. Hantz Financial Services Inc. boosted its position in shares of Teleflex by 248.8% in the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Teleflex in the third quarter valued at about $35,000. True Wealth Design LLC increased its position in Teleflex by 10,333.3% during the second quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock worth $37,000 after acquiring an additional 310 shares during the period. Finally, Quent Capital LLC bought a new position in Teleflex during the third quarter worth about $38,000. 95.62% of the stock is currently owned by institutional investors.

Teleflex Price Performance

Teleflex stock opened at $103.78 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $180.58. The stock has a market capitalization of $4.59 billion, a P/E ratio of -14.12, a price-to-earnings-growth ratio of 1.36 and a beta of 0.92. The stock has a fifty day moving average of $113.96 and a 200-day moving average of $118.93.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on TFX. Wells Fargo & Company decreased their target price on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 29th. Needham & Company LLC upgraded Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price target for the company in a research note on Tuesday, January 27th. Royal Bank Of Canada reissued a “sector perform” rating and set a $135.00 price target on shares of Teleflex in a research report on Wednesday, December 17th. Truist Financial lifted their price objective on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a report on Thursday, December 18th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $139.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.